Early HIV Treatment Prolongs Life

One of the largest clinical drug trials has been stopped a year early because of the undeniably positive results. The federal health officials announced earlier this week that they were ending a clinical trial regarding early treatment for HIV because the trial results were clear early on.
Those conclusive, early results proved that people with HIV who were prescribed antiretroviral drugs at the time of their diagnosis lived longer than those whose treatment with antiretroviral drugs was postponed. The chance of survival increased by over 50 percent and the person was less likely to develop full-blown AIDS or some other serious illness due to their compromised immune system according to Steve Murray on the New York Post.
Early treatment saves lives, that’s the mantra for all diseases, including HIV. Unfortunately, of the estimated 35 million people worldwide who are infected with the AIDS virus, less than half ( 14 million) are participating in a treatment program which includes antiretroviral drugs.
The Centers for Disease Control and Prevention states there are several factors which prevent HIV-positive people from getting an early diagnosis, such as lack of insurance or wrong diagnosis.
Dr. Demetre C. Daskalakis, the NYC health department’s assistant commissioner for H.I.V./AIDS prevention and control, says that treatment is being started quickly for newly diagnosed HIV patients in New York. Dr. Julio S. G. Montaner, a former president of the International AIDS Society, says early treatment is the best way to halt the AIDS epidemic.